AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34265151 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic mesh (Control)
Number of subjects: 76
Study 34265220 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34265285 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation index of HOXA1 (MI_H)
Number of subjects: 67
Study 34265285 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation index of NEUROG1 (MI_N)
Number of subjects: 67
Study 34265285 — intervention group
Group type: COMPARATOR
Intervention: Brush cytology
Number of subjects: 67
Study 34265285 — intervention group
Group type: COMPARATOR
Intervention: Serum carbohydrate antigen 19-9 (CA19-9)
Number of subjects: 67
Study 34265285 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of brush cytology, MI_H, MI_N, and CA19-9
Number of subjects: 67
Study 34265285 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation markers
Number of subjects: 67
Study 34265394 — intervention group
Group type: EXPERIMENTAL
Intervention: High-field MR-Linac treatment
Number of subjects: 943
Study 34265433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensartinib at a dose of 225 mg once daily
Number of subjects: 59
Study 34266311 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical or transcatheter aortic valve replacement
Number of subjects: 0
Study 34266343 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain fitness (B-Fit) utilizing education and goal setting
Number of subjects: 130
Study 34266343 — intervention group
Group type: EXPERIMENTAL
Intervention: Education-only
Number of subjects: 130
Study 34266343 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 130
Study 34266389 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based football program
Number of subjects: 39
Study 34266407 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFIRINOX
Number of subjects: 49
Study 34266407 — intervention group
Group type: COMPARATOR
Intervention: Gemox
Number of subjects: 49
Study 34266444 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented Attune mobile bearing TKA
Number of subjects: 0
Study 34266463 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright Walking Task
Number of subjects: 55
Study 34266463 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward Leaning Trunk (FLT) Walking Task
Number of subjects: 55
Study 34266463 — intervention group
Group type: COMPARATOR
Intervention: nLBP group
Number of subjects: 55
Study 34266505 — intervention group
Group type: EXPERIMENTAL
Intervention: VigilanS brief contact intervention (BCI) including resource cards, telephone calls, and postcards
Number of subjects: 10666
Study 34266505 — intervention group
Group type: EXPERIMENTAL
Intervention: VigilanS brief contact intervention (BCI)
Number of subjects: 10666
Study 34266583 — intervention group
Group type: EXPERIMENTAL
Intervention: Orodispersible Ticagrelor
Number of subjects: 0
Study 34266583 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34266694 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 350
Study 34266842 — intervention group
Group type: EXPERIMENTAL
Intervention: Data collection from participants during the first 72 hours of hospitalization, including vital parameters and electrophysiological waveforms.
Number of subjects: 151
Study 34266842 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up data collection at 3 months, 1 year, 2 years, and 5 years after ED visit.
Number of subjects: 151
Study 34266941 — intervention group
Group type: EXPERIMENTAL
Intervention: CVR max (highest CPM volume ratio) in term infants (n=351)
Number of subjects: 383
Study 34266941 — intervention group
Group type: EXPERIMENTAL
Intervention: CVR max and gestational age in preterm infants (n=32)
Number of subjects: 383
Study 34266941 — intervention group
Group type: EXPERIMENTAL
Intervention: CVR first (first CPM volume ratio)
Number of subjects: 383
Study 34266942 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning (n=505)
Number of subjects: 827
Study 34266942 — intervention group
Group type: COMPARATOR
Intervention: Awake supine positioning (n=322)
Number of subjects: 827
Study 34266943 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-driven volumetric quantification of CF-related modifications
Number of subjects: 184
Study 34266943 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel scoring system for disease outcome
Number of subjects: 184
Study 34267079 — intervention group
Group type: EXPERIMENTAL
Intervention: Next generation epigenetic modulators
Number of subjects: 0
Study 34267079 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergistic drug combination regimens
Number of subjects: 0
Study 34268122 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic Immune-Inflammation Index (SII) > 510
Number of subjects: 1072
Study 34268122 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on SII and other factors (CA19-9, tumor differentiation, T stage, N stage, margin status)
Number of subjects: 1072
Study 34268122 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1072
Study 34268321 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-testing for HIV
Number of subjects: 0
Study 34268359 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnion group (Foley catheter with sterilized freeze-dried amnion graft)
Number of subjects: 30
Study 34268359 — intervention group
Group type: COMPARATOR
Intervention: Control group (Foley catheter without amnion graft)
Number of subjects: 30
Study 34268393 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung injury burden (LIB) in survivors
Number of subjects: 105
Study 34268393 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP/InDels
Number of subjects: 105
Study 34268393 — intervention group
Group type: EXPERIMENTAL
Intervention: LIB combined with APACHE II score
Number of subjects: 105
Study 34268406 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 88
Study 34268406 — intervention group
Group type: COMPARATOR
Intervention: High-dose octreotide
Number of subjects: 88
Study 34268426 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive treatments including types of oxygen support, ventilation, rescue therapies for hypoxemia, other adjunctive and supportive treatments, experimental therapies
Number of subjects: 0
Study 34268513 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic heparin
Number of subjects: 465
Study 34268513 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic heparin
Number of subjects: 465
Study 34268623 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0.5 ng/mL
Number of subjects: 11
Study 34268623 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 1.0 ng/mL
Number of subjects: 11
Study 34268623 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 1.5 ng/mL
Number of subjects: 11
Study 34268711 — intervention group
Group type: EXPERIMENTAL
Intervention: IMC-001 (PD-L1 blocker) administered intravenously every 2 weeks at doses ranging from 2 to 20 mg/kg
Number of subjects: 15
Study 34269152 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib and Vistusertib combination therapy
Number of subjects: 25
Study 34269152 — intervention group
Group type: COMPARATOR
Intervention: Acalabrutinib
Number of subjects: 25
Study 34269152 — intervention group
Group type: COMPARATOR
Intervention: Vistusertib
Number of subjects: 25
Study 34269152 — intervention group
Group type: COMPARATOR
Intervention: Circulating tumor DNA dynamics
Number of subjects: 25
Study 34269698 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid chromatography-tandem mass spectrometry method for monitoring medication adherence
Number of subjects: 92
Study 34269712 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate ketogenic diet (LCKD)
Number of subjects: 0
Study 34269712 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34269847 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy to the prostate region
Number of subjects: 18
Study 34269847 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy to prostate and pelvic nodal regions
Number of subjects: 18
Study 34269847 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger irradiated volumes
Number of subjects: 18
Study 34269908 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 0
Study 34269908 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 34269911 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN) added to catheter ablation
Number of subjects: 0
Study 34269911 — intervention group
Group type: COMPARATOR
Intervention: Catheter ablation alone
Number of subjects: 0
Study 34269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tocilizumab (IV-TCZ) 4 mg/kg
Number of subjects: 54
Study 34269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline US34-PDUS
Number of subjects: 54
Study 34269927 — intervention group
Group type: EXPERIMENTAL
Intervention: US34-PDUS, CDAI, DAS28-ESR
Number of subjects: 54
Study 34269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PDUS and 12-week PDUS change
Number of subjects: 54
Study 34269927 — intervention group
Group type: EXPERIMENTAL
Intervention: DAS28-ESR and CDAI
Number of subjects: 54
Study 34269927 — intervention group
Group type: EXPERIMENTAL
Intervention: HAQ-DI
Number of subjects: 54
Study 34270325 — intervention group
Group type: EXPERIMENTAL
Intervention: High sugar-sweetened beverage (SSB) consumers
Number of subjects: 122819
Study 34270325 — intervention group
Group type: COMPARATOR
Intervention: Control group (lower SSB consumers)
Number of subjects: 122819
Study 34270347 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitors and Insulin Pumps
Number of subjects: 0
Study 34270444 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered digital trainings prior to and during rehabilitation stay
Number of subjects: 1812
Study 34270444 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosomatic rehabilitation treatment
Number of subjects: 1812
Study 34270444 — intervention group
Group type: COMPARATOR
Intervention: General population
Number of subjects: 1812
Study 34270445 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised and internationally validated psychiatric assessments (Diagnosis Infant and Preschool Assessment, Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version)
Number of subjects: 0
Study 34270445 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised psychiatric assessments during five visits (baseline, 1 week after baseline, 1 month after baseline, 1 week after the end of the containment, and 1 month after the end of the containment)
Number of subjects: 0
Study 34270522 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable sensor (Empatica E4)
Number of subjects: 46
Study 34270522 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained model on withheld data
Number of subjects: 46
Study 34270700 — intervention group
Group type: EXPERIMENTAL
Intervention: Early RA (ESPOIR cohort)
Number of subjects: 1489
Study 34270700 — intervention group
Group type: EXPERIMENTAL
Intervention: Early SpA (DESIR cohort)
Number of subjects: 1489
Study 34270700 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings for both diseases
Number of subjects: 1489
Study 34270905 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 0
Study 34271077 — intervention group
Group type: EXPERIMENTAL
Intervention: School- and community-based intervention to promote healthy lifestyle
Number of subjects: 0
Study 34271077 — intervention group
Group type: EXPERIMENTAL
Intervention: School- and community-based intervention
Number of subjects: 0
Study 34271077 — intervention group
Group type: EXPERIMENTAL
Intervention: School- and community-based intervention for low-risk families
Number of subjects: 0
Study 34271077 — intervention group
Group type: EXPERIMENTAL
Intervention: School- and community-based intervention for high-risk families
Number of subjects: 0
Study 34271077 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 0
Study 34271077 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental financial investments for high-risk families
Number of subjects: 0
Study 34271131 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 °C
Number of subjects: 680
Study 34271131 — intervention group
Group type: COMPARATOR
Intervention: Targeted temperature management (TTM) at 36 °C
Number of subjects: 680
Study 34271173 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous implantable cardioverter-defibrillator (S-ICD)
Number of subjects: 1254
Study 34271312 — intervention group
Group type: EXPERIMENTAL
Intervention: IDH1-vac, a long IDH1R132H peptide vaccine
Number of subjects: 0
Study 34271528 — intervention group
Group type: EXPERIMENTAL
Intervention: externally-paced deep breathing
Number of subjects: 25
Study 34271528 — intervention group
Group type: EXPERIMENTAL
Intervention: self-paced deep breathing
Number of subjects: 25
Study 34271528 — intervention group
Group type: COMPARATOR
Intervention: sitting quietly
Number of subjects: 25
Study 34271528 — intervention group
Group type: EXPERIMENTAL
Intervention: self-paced Sheetali/Sheetkari pranayama
Number of subjects: 25
Study 34271528 — intervention group
Group type: EXPERIMENTAL
Intervention: externally paced Sheetali/Sheetkari pranayama
Number of subjects: 25
Study 34271913 — intervention group
Group type: EXPERIMENTAL
Intervention: MapSan intervention (shared sanitation facilities)
Number of subjects: 0
Study 34271913 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 0
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-worn devices (Actical, ActiGraph GT3X+, SW-200)
Number of subjects: 117
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh-worn devices (activPAL)
Number of subjects: 117
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-worn devices (StepWatch)
Number of subjects: 117
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-worn devices (ActiGraph GT3X+)
Number of subjects: 117
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: All wearable technologies
Number of subjects: 117
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed and wear location
Number of subjects: 117
Study 34271922 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 117
Study 34272087 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 0
Study 34272087 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic therapies
Number of subjects: 0
Study 34272204 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative systemic treatment (usual care arm of GAP 70+ Trial)
Number of subjects: 369
Study 34272204 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing age by one year
Number of subjects: 369
Study 34272204 — intervention group
Group type: EXPERIMENTAL
Intervention: Receipt of ≥second line of chemotherapy
Number of subjects: 369
Study 34272204 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional impairment
Number of subjects: 369
Study 34272204 — intervention group
Group type: EXPERIMENTAL
Intervention: Income ≤$50,000
Number of subjects: 369
Study 34272304 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab (Isa)-lenalidomide (Len)-dexamethasone (Dex)
Number of subjects: 57
Study 34272425 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal Doppler monitoring (EDM) during postural change from steep Trendelenburg to supine position (T-off)
Number of subjects: 125
Study 34272425 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal Doppler monitoring (EDM)
Number of subjects: 125
Study 34272471 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive neuromodulation (including ECT, rTMS, tDCS) targeting the prefrontal cortex
Number of subjects: 0
Study 34272471 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive neuromodulation
Number of subjects: 0
Study 34272724 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy
Number of subjects: 237
Study 34272724 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment withdrawal after 180 days
Number of subjects: 237
Study 34272724 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 237
Study 34272797 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 35
Study 34273485 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic treatment
Number of subjects: 1884
Study 34273485 — intervention group
Group type: COMPARATOR
Intervention: Maintenance systemic corticosteroids or uncontrolled by high-dosage inhaled corticosteroids
Number of subjects: 1884
Study 34273526 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplant ePROM (TXP) administered via mobile application
Number of subjects: 232
Study 34273526 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplant ePROM (TXP)
Number of subjects: 232
Study 34273558 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal handgrip exercise test (6MHGT)
Number of subjects: 29
Study 34273904 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab treatment for 52 weeks
Number of subjects: 0
Study 34273963 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) group
Number of subjects: 16533
Study 34273963 — intervention group
Group type: COMPARATOR
Intervention: Non-AF group
Number of subjects: 16533
Study 34274071 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care for Older People (ICOPE) Step 1 screening tool
Number of subjects: 759
Study 34274072 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hysterectomy
Number of subjects: 50286
Study 34274072 — intervention group
Group type: EXPERIMENTAL
Intervention: History of endometriosis
Number of subjects: 50286
Study 34274251 — intervention group
Group type: EXPERIMENTAL
Intervention: Exertional-desaturators during CPET
Number of subjects: 24
Study 34274251 — intervention group
Group type: EXPERIMENTAL
Intervention: Exertional-desaturators during low/moderate-intensity exercise
Number of subjects: 24
Study 34274251 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-exertional-desaturators during high-intensity exercise
Number of subjects: 24
Study 34274251 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral-NIRS indices
Number of subjects: 24
Study 34274293 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation after transcatheter aortic valve replacement
Number of subjects: 0
Study 34274293 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34274393 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) with sequential S-1
Number of subjects: 63
Study 34274536 — intervention group
Group type: EXPERIMENTAL
Intervention: CD5-targeting fully human heavy-chain variable (FHV) CAR-T therapy
Number of subjects: 0
Study 34274536 — intervention group
Group type: COMPARATOR
Intervention: Standard CAR-T therapy (implied control)
Number of subjects: 0
Study 34275061 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose proton pump inhibitor (PPI) therapy for 4 weeks
Number of subjects: 31
Study 34275061 — intervention group
Group type: EXPERIMENTAL
Intervention: External upper esophageal sphincter (UES) compression device (Reflux Band) nightly along with PPI for 4 weeks
Number of subjects: 31
Study 34275122 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 1568
Study 34275122 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 1568
Study 34275122 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 1 mg
Number of subjects: 1568
Study 34275122 — intervention group
Group type: COMPARATOR
Intervention: Skin Pain NRS responders
Number of subjects: 1568
Study 34275336 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurements of serum drug concentrations
Number of subjects: 0
Study 34275403 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin 1.8 mg/kg by intravenous infusion on Day 1 of 3-week cycles (maximum 16 cycles)
Number of subjects: 0
Study 34275469 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of breathing rate with Fourier coefficients, signal amplitude, and/or ARIMA coefficients
Number of subjects: 0
Study 34275469 — intervention group
Group type: COMPARATOR
Intervention: Breathing rate alone
Number of subjects: 0
Study 34275766 — intervention group
Group type: EXPERIMENTAL
Intervention: PatientsLikeMe (PLM) online patient health community
Number of subjects: 45
Study 34275869 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led HIV self-testing (HIVST) intervention
Number of subjects: 30
Study 34275869 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 30
Study 34275869 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led HIVST
Number of subjects: 30
Study 34276042 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 0
Study 34276042 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies (in general)
Number of subjects: 0
Study 34276042 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting IL-6 and IL-6R
Number of subjects: 0
Study 34276329 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 74
Study 34276329 — intervention group
Group type: COMPARATOR
Intervention: Stretching/Toning
Number of subjects: 74
Study 34276537 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine Receptor D1
Number of subjects: 0
Study 34276547 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34277060 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulse oscillometry measurements
Number of subjects: 567
Study 34277393 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Endocrine Therapy (NET) with gonadotropin-releasing hormone agonist and tamoxifen
Number of subjects: 187
Study 34277393 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant Chemotherapy (NCT) with adriamycin plus cyclophosphamide followed by taxane
Number of subjects: 187
Study 34277393 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Endocrine Therapy (NET)
Number of subjects: 187
Study 34277393 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant Chemotherapy (NCT)
Number of subjects: 187